COVID took the world by stunned surprise – but, to quote an old Who song, we won't be fooled again.
That's thanks to accelerated genome sequencing technologies, expanded laboratory capabilities, and interacting infrastructure on a global level. These factors are converging to enable both identification of novel infectious diseases as well as microbial resistance, before these threats can impact public health, write a team from the European Society for Clinical Microbiology and Infectious Diseases in Frontiers in Science.
To continue reading, go to DNA Science, where this post first appeared.
Published on June 28, 2024 22:00